Longaeva Partners’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
Other funds holding VERA
KCM
Longaeva Partners's VERA Position: Q3 2026 in Review
Longaeva Partners opened a new position in Vera Therapeutics (VERA) in Q3 2026: 453,687 shares worth $14.6M. The stake represents 0.3% of the portfolio and ranks #84 among its holdings.
222 funds tracked by Wall St. Rank hold VERA as of Q3 2026.
- Longaeva Partners held 453,687 shares of Vera Therapeutics worth $14.6M as of Q3 2026.
- Vera Therapeutics was a new Longaeva Partners position in Q3 2026.
- Vera Therapeutics made up 0.3% of Longaeva Partners's portfolio in Q3 2026, its #84 holding.
- 222 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.
Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.